This Week in Science

In this week's Science, a multi-institute group of researchers argue for a balance between precaution and innovation when it comes to the use of gene-manipulating technologies. While some have urged extreme caution when it comes to the use of technologies such as gene drives — calling for strict evaluation and testing before they are put into widespread use — others maintain that over-zealous restrictions hamper technological development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.